Insights

Case studies and field notes from real plants

Real customer success stories, real ROI, real decision capital.

Case studyPharmaSPC

Global pharma: SPC across thousands of quality parameters

Live SPC in Seeq for thousands of quality parameters, generated from the data tree instead of built chart by chart.

1,000squality parameters under live SPC
Case studyPharmaSeeq · OEE

Global pharma: making operator and automatic downtime tell one story

Operator-logged and automatic downtime were reported side by side and double-counted. One per-step number now reconciles them.

3 → 1downtime rows per step, reconciled into one number
Case studyPharmaSeeq · OEE

Top-10 pharma: OEE+ across drug substance, drug product and packaging

An OEE+ solution in Seeq and Power BI, scaled to 7+ sites across drug substance, drug product and packaging.

10%estimated capacity increase
Case studyPharmaSeeq · CPV

Top-10 pharma: asset qualification monitoring by exception

A Seeq add-on for asset qualification monitoring by exception (CPV), deploying to 10+ sites with AI-assisted analysis.

8 hestimated time saved per engineer per line
Case studyPharmaSeeq · Asset health

Top-10 pharma: equipment health monitoring

Process data, alarms, work orders and deviations combined into one weighted health score for every piece of equipment.

[XX][headline result]
Case studyBiotechSeeq · Asset health

Global biotech: automated asset health scoring at scale

Automated health scoring for 800+ assets across 35+ buildings, replacing annual reviews with live analysis.

800+assets scored automatically
Case studyOil & gasSeeq · Energy

US refiner: an enterprise energy sustainability platform

An energy sustainability platform scaled to every refinery in the fleet, supporting a broader enterprise savings goal.

6refineries on one energy platform

Start with one process question

Got a historian full of data and no time to use it?

In a 30-minute call we’ll talk through your process and sketch the first analysis worth building.In a 30-minute call we’ll sketch the first analysis worth building.